Search Results
are involved in the parasite transmission to seronegative recipients. It is unclear whether T. gondii can be transmitted by surgical procedures other than organ transplant. It is also unknown whether the use of contaminated materials during surgery
species. ESX-4 The ESX-4 system is involved in the secretion of effectors that are required in the conjugation process, especially in the mycobacterial receiver strains. From a donor: recipient co-culture study, an ESX-1 mediated expression of ESX-4 genes
-like plasmid from coinfecting vancomycin-resistant enterococci [ 12 ]. The transfer of this plasmid requires the presence of a pSK41-like plasmid in recipient S. aureus [ 49 ]. In our study, however, the only VRSA isolate neither contains vanA nor
6. Robert-Gangneux F , Meroni V , Dupont D , Botterel F , Garcia JMA , Brenier-Pinchart MP , Toxoplasmosis in transplant recipients, Europe, 2010–2014 . Emerg Infect Dis . 2018 ; 24 ( 8 ): 1497 – 504 . https://doi.org/10
parasitic infection dose down to one T. gondii cyst per recipient animal only. Depending on the virulence of the respective T. gondii strain and the age and sex of the susceptible mice [ 3 ], an accidental increase in cyst number might result in a much
recipients . Semin Nephrol 27 , 445 – 461 ( 2007 ) 21. Martina MN , Cervera C , Esforzado N , Linares L , Torregrosa V , Sanclemente G , Hoyo
) 12. Laifer SA , Ehrlich GD , Huff DS , Balsan MJ , Scantlebury VP : Congenital cytomegalovirus infection in offspring of liver transplant recipients . Clin Infect
extraction in conjunction with three commercially available real-time PCR assays for quantitation of plasma Cytomegalovirus DNAemia in allogeneic stem cell transplant recipients. J Clin Microbiol 49, 2899–2904 (2011
Lark RL, McNeil SA, VanderHyde K, Noorani A, Uberti J, Chenoweth C: Risk factors for anaerobic bloodstream infections in bone marrow transplant recipients. Clin Infect Dis 33, 338–343 (2001) Chenoweth C
, Yang H , McClain JB : Safety profile, pharmacokinetics, and pharmacodynamics of siplizumab, a humanized anti-CD2 monoclonal antibody, in renal allograft recipients . Transplant Proc 41 , 3655 – 3661 ( 2009 ) 4
